News | RIVM

Report on the developments of the National Immunisation Programme: national immunisation coverage increased slightly for the first time in five years

National immunisation coverage has increased for the first time in five years, for almost all vaccinations. For children born in 2017, vaccination coverage against mumps, measles and rubella (MMR) increased by 0.7% to 93.6%.

Can you solve a medical mystery?

During World Antibiotic Awareness Week 2019, RIVM has set up an escape room in one of busiest shopping malls in the Netherlands.

Updated immunisation recommendation for measles: early vaccination before travel

A number of European countries are currently seeing outbreaks of measles. Before the start of the summer season, RIVM has therefore updated its immunisation recommendation for measles.

Risk of measles outbreaks increases with decreasing vaccination coverage

Vaccination coverage for vaccinations in the Dutch National Vaccination Program (NIP) decreased slightly by about half a percent for the third consecutive year.

Bacteria slightly more often resistant to last resort antibiotics

Antimicrobial resistance is a global problem. In the Netherlands, some bacteria that can cause infections in people are more frequently resistant to antibiotics used as a last resort.

Measles epidemic and Salmonella outbreak cost nearly six million euros

The most recent measles epidemic and outbreak of Salmonella Thomson due to smoked salmon have cost 3.9 and 1.7 million euros, respectively.

European Antibiotic Awareness Day: the fight against antibiotics resistance

Wednesday, 18 November is European Antibiotic Awareness Day. On this day, attention throughout Europe is requested for the responsible use of antibiotics in people and animals.

CAESAR annual report 2014

The World Health Organization (WHO) published its first CAESAR annual report 2014.

Antibiotic resistance is stable, however, more resistant bacteria are expected

Over recent years, antibiotic resistance to most agents has remained stable in the Netherlands, and the use of antibiotics has slightly decreased.

RIVM designated as WHO Collaborating Centre Antimicrobial Resistance Epidemiology and Surveillance

AMR is one of the major global challenges in infectious disease control.